A clearer first step for a cancer medicine.
Search the name on the prescription, or browse by cancer type. Medrack.Health provides clear information before a case-specific access assessment.
Or browse by cancer type Understand the process
This is not an emergency service and Medrack.Health does not provide medical advice. For symptoms or treatment decisions, contact the patient’s oncology team.
Start with the prescribed medicine
Each page explains the medicine, common use and safety information, then offers a secure way to request an assessment.
Tagrisso
View medicine information Prostate cancer AbirateroneMetastatic prostate cancer (CYP17 inhibitor).
View medicine information Blood cancers & GIST ImatinibChronic myeloid leukaemia and GIST (tyrosine kinase inhibitor).
View medicine information Breast, colorectal & gastric cancers CapecitabineBreast, colorectal and gastric cancers (oral chemotherapy).
View medicine information Lung cancer GefitinibEGFR-mutation-positive non-small-cell lung cancer (first-generation TKI).
View medicine informationBuilt for patients, caregivers and treating teams
The first step should be clear, without rushing a clinical or cross-border decision.
- Find the medicineStart with the cancer type or the name on the prescription.
- Share the essentialsTell us the prescribed strength, patient destination and prescription status.
- Receive written informationFor an eligible case, review the confirmed details before deciding what to do next.
When the patient, caregiver and treating team are not in the same place
Many access questions begin with a family member trying to help from another city or country. Start with the prescribed medicine and the patient’s local oncology team. If a local option is not workable, use Medrack.Health to ask a focused, case-specific question.
We will not ask you to make a treatment decision, switch medicines or send payment through this website.
Requesting information for someone you love?
You may begin a case request from abroad for a patient in Ghana or Kenya. We will ask for the patient’s name exactly as it appears on the prescription.
Questions about the process? Contact the access team.